Engineering of a vascularized scaffold for artificial tissue and organ generation
- PMID: 15979139
- DOI: 10.1016/j.biomaterials.2005.04.048
Engineering of a vascularized scaffold for artificial tissue and organ generation
Abstract
Tissue engineering is an emerging field in regenerative medicine to overcome the problem of end-stage organ failure. However, complex tissues and organs need a vascular supply to guaranty graft survival and render bioartificial organ function. Here we developed methods to decellularize porcine small bowl segments and repopulate the remaining venous and arterial tubular structures within these matrices with allogeneic porcine endothelial progenitor cells. Cellular adherence and vitality was characterized by quantitative 2-[18F]-fluoro-2'-desoxy-glucose (FDG) positron emission tomography (PET) and subsequent immunohistological work up. The generated matrices showed insulin-dependent FDG uptake predominantly in the region of the former vascular structures. Stain for vitality and the specific endothelial markers CD31, VE-Cadherin and Flk-1 matched this functional finding. Providing evidence for vitality up to 3 weeks post reconstitution and typical endothelial differentiation, these results indicate that our generated matrix allows the generation of complex bioartificial tissues and organs for experimental and future clinical application.
Similar articles
-
Generation and transplantation of an autologous vascularized bioartificial human tissue.Transplantation. 2009 Jul 27;88(2):203-10. doi: 10.1097/TP.0b013e3181ac15e1. Transplantation. 2009. PMID: 19623015
-
Experimental generation of a tissue-engineered functional and vascularized trachea.J Thorac Cardiovasc Surg. 2004 Dec;128(6):900-6. doi: 10.1016/j.jtcvs.2004.07.036. J Thorac Cardiovasc Surg. 2004. PMID: 15573075
-
Collagen-based matrices improve the delivery of transplanted circulating progenitor cells: development and demonstration by ex vivo radionuclide cell labeling and in vivo tracking with positron-emission tomography.Circ Cardiovasc Imaging. 2008 Nov;1(3):197-204. doi: 10.1161/CIRCIMAGING.108.781120. Circ Cardiovasc Imaging. 2008. PMID: 19808543
-
[Tissue engineering: in vitro creation of tissue substitutes].Zentralbl Chir. 2007 Jun;132(3):236-46. doi: 10.1055/s-2007-981159. Zentralbl Chir. 2007. PMID: 17610197 Review. German.
-
Stem cells used for cardiovascular tissue engineering.Eur J Cardiothorac Surg. 2008 Aug;34(2):242-7. doi: 10.1016/j.ejcts.2008.03.067. Epub 2008 May 8. Eur J Cardiothorac Surg. 2008. PMID: 18468449 Review.
Cited by
-
Effects of silk fibroin fiber incorporation on mechanical properties, endothelial cell colonization and vascularization of PDLLA scaffolds.Biomaterials. 2013 Jun;34(19):4573-81. doi: 10.1016/j.biomaterials.2013.02.009. Epub 2013 Mar 19. Biomaterials. 2013. PMID: 23522374 Free PMC article.
-
CDH2 and CDH11 act as regulators of stem cell fate decisions.Stem Cell Res. 2015 May;14(3):270-82. doi: 10.1016/j.scr.2015.02.002. Epub 2015 Feb 19. Stem Cell Res. 2015. PMID: 25771201 Free PMC article. Review.
-
Evaluation of novel decellularizing corneal stroma for cornea tissue engineering applications.Int J Ophthalmol. 2012;5(4):415-8. doi: 10.3980/j.issn.2222-3959.2012.04.02. Epub 2012 Aug 18. Int J Ophthalmol. 2012. PMID: 22937497 Free PMC article.
-
Newer approaches to dry eye therapy: Nanotechnology, regenerative medicine, and tissue engineering.Indian J Ophthalmol. 2023 Apr;71(4):1292-1303. doi: 10.4103/IJO.IJO_2806_22. Indian J Ophthalmol. 2023. PMID: 37026261 Free PMC article. Review.
-
Regenerative Medicine and Nanotechnology Approaches against Cardiovascular Diseases: Recent Advances and Future Prospective.Curr Stem Cell Res Ther. 2025;20(1):50-71. doi: 10.2174/011574888X263530230921074827. Curr Stem Cell Res Ther. 2025. PMID: 38343052 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources